{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:56:53Z","timestamp":1790751413540,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antimicrobial resistance is among the leading causes of global mortality, and artificial intelligence (AI)-based clinical decision support systems (CDSS) have been proposed to guide antibiotic prescribing. Several AI models for antibiotic decision-making have been developed and validated, but their actual deployment in clinical practice and effect on patient outcomes have not been systematically characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify, classify, and appraise studies evaluating AI-based CDSS for antibiotic therapy in hospitalized adults with common infections, stratified by level of clinical implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Search-strategy development began on June 7, 2026; definitive searches of PubMed\/MEDLINE, Scopus, Web of Science Core Collection, and Embase were executed on June 28, 2026, after submission of the PROSPERO record. Four reviewers independently screened records and assessed reports. Studies were classified as deployed in clinical practice (Level 1), evaluated against physicians' decisions without deployment (Level 2), or tested through retrospective simulation (Level 3). Risk of bias was assessed with RoB 2, ROBINS-I, or PROBAST, as appropriate. Owing to clinical and methodological heterogeneity, findings were synthesized narratively, with an outcome-specific GRADE assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 1,157 records identified, 10 studies met the inclusion criteria: three Level 1 (30%), four Level 2 (40%), and three Level 3 (30%). The three deployed studies evaluated pneumonia, predominantly pulmonary\n                      <jats:italic>Stenotrophomonas maltophilia<\/jats:italic>\n                      infection, and\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      bacteremia and reported favorable signals for mortality, hospital processes, prescribing, or medication safety. Kanjilal et al., a published conference abstract, was included as a Level 3 retrospective evaluation of 29,508 adults with community-onset sepsis. Among the seven Level 2\/3 studies assessed with PROBAST, three were classified as low, three as moderate under the prespecified descriptive adaptation, and one as high overall risk of bias. Certainty was low for mortality\/survival and very low for the remaining clinically relevant outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Three of 10 included studies reached clinical deployment, whereas seven remained non-deployed. Deployed systems showed favorable outcome and process signals, but the evidence was heterogeneous and of low to very-low certainty, depending on the outcome. Prospective multicenter evaluations of deployed systems are required before computational performance can be interpreted as clinical effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261435593<\/jats:ext-link>\n                      , identifier CRD420261435593.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fdgth.2026.1944745","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:06:21Z","timestamp":1790748381000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["AI-based clinical decision support systems for antibiotic therapy in common adult infections: a systematic review from development to clinical implementation"],"prefix":"10.3389","volume":"8","author":[{"given":"Miguel","family":"Hueda-Zavaleta","sequence":"first","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Privada de Tacna","place":["Tacna, Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Flores-Palacios","sequence":"additional","affiliation":[{"name":"Hospital Daniel Alcides Carri\u00f3n, Essalud","place":["Tacna, Per\u00fa"]},{"name":"Facultad de Ciencias de la Salud, Universidad Nacional Jorge Basadre Grohmann","place":["Tacna, Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizzio","family":"Bardales-Silva","sequence":"additional","affiliation":[{"name":"Hospital Daniel Alcides Carri\u00f3n, Essalud","place":["Tacna, Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Cotacallapa-Pino","sequence":"additional","affiliation":[{"name":"Hospital Daniel Alcides Carri\u00f3n, Essalud","place":["Tacna, Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Frenkel","sequence":"additional","affiliation":[{"name":"Arkstone Medical Solutions","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Minchon-Vizconde","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Privada de Tacna","place":["Tacna, Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Gomez de la Torre Pretell","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Humana Universidad Ricardo Palma","place":["Lima, Per\u00fa"]},{"name":"Laboratorio Cl\u00ednico Roe","place":["Lima, Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cmi.2019.10.031","article-title":"Burden of bacterial bloodstream infection: a brief update on epidemiology and significance of multidrug-resistant pathogens","volume":"26","author":"Kern","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.amjms.2018.11.009","article-title":"Impact of delayed appropriate antibiotic therapy on patient outcomes by antibiotic resistance status from serious gram-negative bacterial infections","volume":"357","author":"Bonine","year":"2019","journal-title":"Am J Med Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijmedinf.2016.04.008","article-title":"The effectiveness of information technology to improve antimicrobial prescribing in hospitals: a systematic review and meta-analysis","volume":"92","author":"Baysari","year":"2016","journal-title":"Int J Med Inform"},{"key":"B5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cmi.2019.09.009","article-title":"Machine learning for clinical decision support in infectious diseases: a narrative review of current applications","volume":"26","author":"Peiffer-Smadja","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s43856-022-00094-8","article-title":"Personalized antibiograms for machine learning driven antibiotic selection","volume":"2","author":"Corbin","year":"2022","journal-title":"Commun Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1164\/rccm.202109-2092OC","article-title":"A pragmatic, stepped-wedge, cluster-controlled clinical trial of real-time pneumonia clinical decision support","volume":"205","author":"Dean","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/jpm13060951","article-title":"A review of the role of artificial intelligence in healthcare","volume":"13","author":"Al Kuwaiti","year":"2023","journal-title":"J Pers Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/antibiotics13060502","article-title":"Implications of artificial intelligence in addressing antimicrobial resistance: innovations, global challenges, and healthcare's future","volume":"13","author":"Branda","year":"2024","journal-title":"Antibiotics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12916-019-1426-2","article-title":"Key challenges for delivering clinical impact with artificial intelligence","volume":"17","author":"Kelly","year":"2019","journal-title":"BMC Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"105090","DOI":"10.1016\/j.idnow.2025.105090","article-title":"Evaluating the impact of artificial intelligence in antimicrobial stewardship: a comparative meta-analysis with traditional risk scoring systems","volume":"55","author":"Pinto","year":"2025","journal-title":"Infectious Diseases now"},{"key":"B12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3390\/biomedicines13102525","article-title":"Artificial intelligence in the management of infectious diseases in older adults: diagnostic, prognostic, and therapeutic applications","volume":"13","author":"Pinto","year":"2025","journal-title":"Biomedicines"},{"key":"B14","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Br Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13012-025-01453-4","article-title":"Implementing an AI-enhanced clinical decision support system for stenotrophomonas maltophilia: a survey-based randomized controlled trial of antibiotic precision and impact on survival","volume":"20","author":"Lin","year":"2025","journal-title":"Implement Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"107142","DOI":"10.1016\/j.ijantimicag.2024.107142","article-title":"Impact of the implementation of the intelligent antimicrobial system (iAMS) on clinical outcomes among patients with bacteraemia caused by methicillin-resistant staphylococcus aureus","volume":"63","author":"Ho","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0331266","DOI":"10.1371\/journal.pone.0331266","article-title":"Comparison of OneChoice AI-based clinical decision support recommendations with infectious disease specialists and non-specialists for bacteremia treatment in Lima, Peru","volume":"21","author":"G\u00f3mez de la Torre","year":"2026","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/Life15060864","article-title":"AI-based treatment recommendations enhance speed and accuracy in bacteremia management: a comparative study of molecular and phenotypic data","volume":"15","author":"Gomez de la Torre","year":"2025","journal-title":"Life"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.5228753","article-title":"A machine learning-guided clinical decision support system for early antibiotic selection in pseudomonas aeruginosa bloodstream infections among onco-hematology patients: a multicenter study [preprint]","author":"Feng","year":"2025","journal-title":"SSRN"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1038\/s41598-023-30290-y","article-title":"Machine learning model for predicting ciprofloxacin resistance and presence of ESBL in patients with UTI in the ED","volume":"13","author":"Lee","year":"2023","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.2196\/medinform.3445","article-title":"From data to optimal decision making: a data-driven, probabilistic machine learning approach to decision support for patients with sepsis","volume":"3","author":"Tsoukalas","year":"2015","journal-title":"JMIR Med Inform"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.1093\/ofid\/ofac492.582","article-title":"Antimicrobial stewardship for empirical treatment of bloodstream infection using machine learning clinical decision support","volume":"9","author":"Kanjilal","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B25","volume-title":"Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff","year":"2022"},{"key":"B26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cmi.2017.02.028","article-title":"A systematic review of clinical decision support systems for antimicrobial management: are we failing to investigate these interventions appropriately?","volume":"23","author":"Rawson","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41591-019-0548-6","article-title":"Do no harm: a roadmap for responsible machine learning for health care","volume":"25","author":"Wiens","year":"2019","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41591-018-0307-0","article-title":"The practical implementation of artificial intelligence technologies in medicine","volume":"25","author":"He","year":"2019","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/make8010015","article-title":"Artificial intelligence models for forecasting mosquito-borne viral diseases in human populations: a global systematic review and comparative performance analysis","volume":"8","author":"Pennisi","year":"2026","journal-title":"Mach Learn Knowl Extr"},{"key":"B31","first-page":"1","article-title":"2017\/745 Of the European parliament and of the council of 5 April 2017 on medical devices (MDR)","year":"2017","journal-title":"Off. J. Eur. Union"},{"key":"B32","article-title":"2024\/1689 Of the European parliament and of the council of 13 June 2024 laying down harmonised rules on artificial intelligence (artificial intelligence act)","year":"2024","journal-title":"Off J Eur Union"},{"key":"B33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/make8040093","article-title":"Comparative diagnostic performance of artificial intelligence versus conventional approaches for early detection of mosquito-borne viral infections: a systematic review and meta-analysis, with evidence predominantly from dengue studies","volume":"8","author":"Pennisi","year":"2026","journal-title":"Mach Learn Knowl Extr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"key":"B35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1748-5908-8-139","article-title":"Implementation strategies: recommendations for specifying and reporting","volume":"8","author":"Proctor","year":"2013","journal-title":"Implement Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3390\/diagnostics16121827","article-title":"Artificial intelligence in infectious disease care: selected applications in tuberculosis, sepsis, and antimicrobial stewardship","volume":"16","author":"Caliman-Sturdza","year":"2026","journal-title":"Diagnostics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13756-026-01731-w","article-title":"Strategies and outcomes of CDSS implementation for antimicrobial stewardship in hospital settings: a systematic review","volume":"15","author":"Giordano","year":"2026","journal-title":"Antimicrob Resist Infect Control"},{"key":"B39","doi-asserted-by":"publisher","first-page":"m689","DOI":"10.1136\/bmj.m689","article-title":"Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies","volume":"368","author":"Nagendran","year":"2020","journal-title":"Br Med J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1944745\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:06:22Z","timestamp":1790748382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1944745\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":40,"alternative-id":["10.3389\/fdgth.2026.1944745"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2026.1944745","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1944745"}}